Spinal Fusion News and Research RSS Feed - Spinal Fusion News and Research

Exploring better treatment for adolescent idiopathic scoliosis

Exploring better treatment for adolescent idiopathic scoliosis

Adolescent idiopathic scoliosis (AIS) affects 2-3% of children aged between 10 and 16. It is more common in girls than in boys (with a ratio of 10-1). Besides the obvious physical signs derived from the visible spinal deformity, AIS can cause psychological and emotional problems (low self-esteem, poor self-image body, etc.) that significantly reduces patients' quality of life. [More]
St. Mary's wins Distinguished Hospital Award for Clinical Excellence for second consecutive year

St. Mary's wins Distinguished Hospital Award for Clinical Excellence for second consecutive year

Dignity Health St. Mary's Medical Center has received the Distinguished Hospital Award for Clinical Excellence™ from Healthgrades, the leading online resource for comprehensive information about physicians and hospitals. This is the second consecutive year St. Mary's has received this award, which recognizes St. Mary's as among the top five percent of more than 4,500 hospitals nationwide for clinical performance. [More]
Amedica's CASCADE data shows silicon nitride spacers are comparable to hollow-body PEEK spacers

Amedica's CASCADE data shows silicon nitride spacers are comparable to hollow-body PEEK spacers

Amedica Corporation, a biomaterial company that develops and commercializes silicon nitride ceramics, today released the results of its CASCADE study, a blinded, randomized clinical trial that compared outcomes of spinal fusion surgery between its composite silicon nitride spacers manufactured with a central core of cancellous structured ceramic (CsC), to the gold standard, i.e., PEEK (polyether ether ketone plastic) spacers filled with bone autograft. [More]
Benvenue Medical's Luna 360 System receives FDA clearance for spinal fusion treatment of DDD

Benvenue Medical's Luna 360 System receives FDA clearance for spinal fusion treatment of DDD

Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, today announced that the company's Luna 360 Interbody Fusion System has received 510(k) clearance from the U.S. Food and Drug Administration for spinal fusion treatment of symptomatic degenerative disc disease (DDD). [More]
University of Vermont Medical Center recognized with 2014 Partnership in Prevention Award

University of Vermont Medical Center recognized with 2014 Partnership in Prevention Award

The U.S. Department of Health and Human Services, the Association for Professionals in Infection Control and Epidemiology, and the Society for Healthcare Epidemiology of America today recognized the University of Vermont Medical Center with the 2014 Partnership in Prevention Award for achieving sustainable improvements toward eliminating healthcare-associated infections (HAIs). [More]
DePuy Synthes releases ViviGen Cellular Bone Matrix for repairing musculoskeletal defects

DePuy Synthes releases ViviGen Cellular Bone Matrix for repairing musculoskeletal defects

DePuy Synthes Companies of Johnson & Johnson, in collaboration with LifeNet Health, today announced the introduction of ViviGen Cellular Bone Matrix, a differentiated cellular allograft for the repair or reconstruction of musculoskeletal defects. [More]
DePuy Synthes releases ViviGen Cellular Bone Matrix for repairing musculoskeletal defects

DePuy Synthes releases ViviGen Cellular Bone Matrix for repairing musculoskeletal defects

DePuy Synthes Companies of Johnson & Johnson, in collaboration with LifeNet Health®, today announced the introduction of ViviGen™ Cellular Bone Matrix, a differentiated cellular allograft for the repair or reconstruction of musculoskeletal defects. [More]
Amedica, Spinal Kinetics sign multi-year OEM agreement for silicon nitride spinal implants

Amedica, Spinal Kinetics sign multi-year OEM agreement for silicon nitride spinal implants

Amedica Corporation, a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopedic implants, is pleased to announce that it has entered into a multi-year original equipment manufacturer (OEM) agreement with Spinal Kinetics, a leading innovator of advanced spinal implant technologies. [More]
MEDICREA receives FDA clearance for world’s first patient-specific spinal osteosynthesis rod

MEDICREA receives FDA clearance for world’s first patient-specific spinal osteosynthesis rod

The MEDICREA Group, a company that specializes in the development of personalized implants produced for a patient’s specific need in the treatment of spinal pathologies, today announced the company has received 510(k) clearance from the U.S. Food and Drug Administration for UNiD, the world’s first patient-specific spinal osteosynthesis rod. [More]
Amedica, Spinal Kinetics sign strategic agreement for silicon nitride spinal interbody fusion devices

Amedica, Spinal Kinetics sign strategic agreement for silicon nitride spinal interbody fusion devices

Amedica Corporation, a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopaedic implants, is pleased to announce that it has entered into a multi-year private labeling agreement with Spinal Kinetics, a leading innovator of advanced artificial spinal disc technology. [More]
Basic yoga pose reduces idiopathic scoliosis curves for adolescent, adult patients

Basic yoga pose reduces idiopathic scoliosis curves for adolescent, adult patients

A basic yoga pose, done for an average of only 1.5 minutes a day, six days a week for two months, reduced idiopathic scoliosis curves for adolescent and adult patients an average of 32% in the first peer-reviewed published clinical trial studying yoga for the reduction of scoliosis curves. [More]

Amedica releases Valeo II TL silicon nitride interbody fusion devices

Amedica Corporation, a commercial biomaterial company focused on silicon nitride ceramics as a material platform to develop, manufacture and sell novel medical devices, is pleased to announce the release of its second generation silicon nitride transforaminal lumbar (TL) interbody fusion device. [More]
New spinal fixation technique: an interview with Dr. Ian Armstrong, Medical Director, Southern California Spine Institute

New spinal fixation technique: an interview with Dr. Ian Armstrong, Medical Director, Southern California Spine Institute

Traditionally, the most commonly used medical devices for spinal fusion procedures have been pedicle screws and rods, and interbody cages or spacers. Each are coupled with bone grafts and limit movement while the area being fused heals. [More]
Mortality rates decrease for hip and knee replacement surgeries in older patients

Mortality rates decrease for hip and knee replacement surgeries in older patients

Over the past decade, a greater number of patients, age 80 and older, are having elective orthopaedic surgery. [More]
Anti-clotting treatment not needed for all kids who undergo spine operations

Anti-clotting treatment not needed for all kids who undergo spine operations

Blood clots occur so rarely in children undergoing spine operations that most patients require nothing more than vigilant monitoring after surgery and should be spared risky and costly anti-clotting medications, according to a new Johns Hopkins Children's Center study. [More]
St. Mary's Medical Center honored with Healthgrades 2014 Women's Health Excellence Award

St. Mary's Medical Center honored with Healthgrades 2014 Women's Health Excellence Award

Dignity Health St. Mary's Medical Center has received the 2014 Women's Health Excellence Award from Healthgrades, the leading online resource for comprehensive information about physicians and hospitals. [More]
First Edition: February 25, 2014

First Edition: February 25, 2014

Today's headlines include stories exploring the political dynamics governors face regarding the health law's Medicaid expansion. [More]
Sedation before nerve block significantly increases false-positive results, shows study

Sedation before nerve block significantly increases false-positive results, shows study

New research suggests that sedating patients before a nerve block needed to diagnose or treat chronic pain increases costs, risks and unnecessary surgeries, and sedation does nothing to increase patient satisfaction or long-term pain control. [More]

DePuy Synthes Spine signs representative agreement for marketing LifeNet Health's cellular allografts

DePuy Synthes Spine and DePuy Synthes Biomaterials, divisions of DePuy Orthopaedics, Inc., announced today they have entered into an exclusive worldwide representative agreement for the marketing and promotion of a new cellular allograft product developed by LifeNet Health, a world leader in allograft bio-implants and cellular therapies. [More]
DePuy Synthes Spine announces the U.S. launch of new tissue implant for spine fusion surgery

DePuy Synthes Spine announces the U.S. launch of new tissue implant for spine fusion surgery

DePuy Synthes Spine, in collaboration with DePuy Synthes Biomaterials, announced today the U.S. launch of CONFORM SHEET, a hydrated, pliable and totally demineralized cancellous bone matrix that fills voids during posterolateral spinal fusion surgery and provides a natural scaffold for new bone formation. [More]